Aarti Drugs says promoter Chandrakant Gogri has died and is no longer classed as promoter
- Management change
- pharmaceuticals

Aarti Drugs (NSE: AARTIDRUGS) said Chandrakant Vallabhaji Gogri, its Chairman Emeritus and Promoter, died on 15 Nov 2026, it said in a filing on 15 Nov 2026. The company says he ceases to be classified as a Promoter consequent to his demise.
Demise and reclassification as promoter
Aarti Drugs says Shri Chandrakant Vallabhaji Gogri, Chairman Emeritus and Promoter of the Company, passed away on 15 Nov 2026, a Sunday. The filing is signed by Rushikesh Deole, Company Secretary and Compliance Officer.
The company states that, under Regulation 31A(6)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gogri ceases to be classified as a Promoter consequent to his demise. Regulation 31A deals with the classification of promoters and promoter group members.
The company says Gogri played a pivotal role in its growth and development over the years, and that his leadership, commitment to excellence and values left an indelible mark on the company. It placed on record its gratitude for his contributions and enduring legacy.
What the reclassification means for Aarti Drugs' shareholders
The change is to how Gogri is classified after his death; the filing does not describe any change to the company's business. The filing does not state the Gogri family's or the deceased promoter's shareholding in the company, the effect of the reclassification on the promoter group's holding, or who will take over any role Gogri held.
At a glance
| Item | Detail |
|---|---|
| Deceased | Chandrakant Vallabhaji Gogri, Chairman Emeritus and Promoter |
| Date of demise | 15 Nov 2026 |
| Status after demise | Ceases to be classified as a Promoter |
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
